Track ACRS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
ACRS - Aclaris Therapeutics Inc (ACRS) has a earnings per share of -$0.15, down 25.0% over the past year.
Latest EPS (Actual)
-$0.15
Beat Rate
37.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.16 | -$0.15 | Beat | +6.25% |
| Feb 2026 | -$0.15 | -$0.16 | Miss | -6.67% |
| Nov 2025 | -$0.14 | -$0.12 | Beat | +14.29% |
| Aug 2025 | -$0.13 | -$0.13 | Meet | +0.00% |
| May 2025 | -$0.12 | -$0.12 | Meet | +0.00% |
| Feb 2025 | -$0.38 | -$1.01 | Miss | -169.33% |
| Nov 2024 | -$0.01 | -$0.11 | Miss | -1000.00% |
| Aug 2024 | -$0.20 | -$0.15 | Beat | +25.00% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.